EX-23.2 3 ceru-ex232_31.htm EX-23.2 ceru-ex232_31.htm

EXHIBIT 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report relating to the consolidated financial statement of Cerulean Pharma Inc. (the “Company”) dated March 10, 2016 appearing in the Annual Report on Form 10-K of the Company for the year ended December 31, 2015.

/s/ Deloitte & Touche LLP

Boston, MA

May 27, 2016